Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
Médium:	Článek
Jazyk:	angličtina
Vydáno:	Philipps-Universität Marburg 2023
Témata:	correlates of protection; nucleoprotein Modified Vaccinia virus Ankara vaccine glycoprotein Medizin Ebola virus Medical sciences Medicine
On-line přístup:	Plný text ve formátu PDF
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!